Table 1

Checklist for reporting of prophylactic gastrectomy specimens

1. Features of ≥pT1b carcinoma(s)Growth pattern (diffuse infiltration vs localised tumour)
Anatomic location (cardia, fundus, body, transitional zone, antrum)
Histological type according to WHO89 and Laurén's90 classifications
Lymphatic, venous and neural invasion (present or absent)
Tumour, node, metastases stage
2. Features of intramucosal precursor lesions and pT1a SRCCNumber of lesions
Anatomic location (cardia, fundus, body, transitional zone, antrum)
Aggressive features: pleomorphism, loss of mucin, spindle cells, small cells, mitoses
Stromal reaction related to lesions: desmoplasia; lymphocytic, eosinophilic or granulomatous inflammatory reaction
Surgical margin status (proximal oesophageal, distal duodenal mucosa, including donuts), to confirm there is no residual gastric mucosa and no tumour at margins.
Lymph node status
3. Non-neoplastic mucosa: changes more commonly seen in this conditionTufting/hyperplastic mucosal changes
Surface epithelial vacuolisation
Globoid change
4. Other findings in surrounding mucosaInflammation (acute, chronic, erosion, ulceration)
Helicobacter pylori
Intraepithelial lymphocytes
Lymphoid infiltrates
Glandular atrophy
Intestinal metaplasia
Adenomatous dysplasia
  • SRCC, signet ring cell carcinoma.